Search

everythinglearnresearchcommunity

for

Search:↓

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Spironolactone most effective for hirsutism, but has side effects.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Diane 35 plus finasteride is more effective for treating hirsutism.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Flutamide reduces hair growth better but has more side effects.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Finasteride safely reduces excessive hair growth in women.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.